BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 26305906)

  • 1. Curcumin Improves the Tumoricidal Effect of Mitomycin C by Suppressing ABCG2 Expression in Stem Cell-Like Breast Cancer Cells.
    Zhou Q; Ye M; Lu Y; Zhang H; Chen Q; Huang S; Su S
    PLoS One; 2015; 10(8):e0136694. PubMed ID: 26305906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing Chemosensitivity of Breast Cancer Stem Cells by Downregulating SOX2 and ABCG2 Using Wedelolactone-encapsulated Nanoparticles.
    Das S; Mukherjee P; Chatterjee R; Jamal Z; Chatterji U
    Mol Cancer Ther; 2019 Mar; 18(3):680-692. PubMed ID: 30587555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABCG2 is a potential marker of tumor-initiating cells in breast cancer.
    Sicchieri RD; da Silveira WA; Mandarano LR; de Oliveira TM; Carrara HH; Muglia VF; de Andrade JM; Tiezzi DG
    Tumour Biol; 2015 Dec; 36(12):9233-43. PubMed ID: 26091795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary study of the effects of β-elemene on MCF-7/ADM breast cancer stem cells.
    Dong Y; Li L; Wang L; Zhou T; Liu JW; Gao YJ
    Genet Mol Res; 2015 Mar; 14(1):2347-55. PubMed ID: 25867381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound reverses chemoresistance in breast cancer stem cell like cells by altering ABCG2 expression.
    Guo L; Zheng P; Fan H; Wang H; Xu W; Zhou W
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28935760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
    Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
    Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.
    Hu J; Zhang X; Wang F; Wang X; Yang K; Xu M; To KK; Li Q; Fu L
    Oncotarget; 2015 Dec; 6(42):44643-59. PubMed ID: 26556876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phytoestrogen genistein enhances multidrug resistance in breast cancer cell lines by translational regulation of ABC transporters.
    Rigalli JP; Tocchetti GN; Arana MR; Villanueva SS; Catania VA; Theile D; Ruiz ML; Weiss J
    Cancer Lett; 2016 Jun; 376(1):165-72. PubMed ID: 27033456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyl-CoA synthetase-4 is implicated in drug resistance in breast cancer cell lines involving the regulation of energy-dependent transporter expression.
    Orlando UD; Castillo AF; Medrano MAR; Solano AR; Maloberti PM; Podesta EJ
    Biochem Pharmacol; 2019 Jan; 159():52-63. PubMed ID: 30414939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of breast cancer resistance protein and p-glycoprotein in residual breast cancer tissue after chemotherapy and its correlation with cancer stem cells].
    Qu HB; Fan YM; Han ML; Luo HJ; Xie J; Liu H; Liu H; Wu CY; Tang WX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Apr; 35(2):171-6. PubMed ID: 23643006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional targeting of human liver carboxylesterase (hCE1m6) and simultaneous expression of anti-BCRP shRNA enhances sensitivity of breast cancer cells to CPT-11.
    Mishra MN; Vangara KK; Palakurthi S
    Anticancer Res; 2014 Nov; 34(11):6345-51. PubMed ID: 25368234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consecutive salinomycin treatment reduces doxorubicin resistance of breast tumor cells by diminishing drug efflux pump expression and activity.
    Hermawan A; Wagner E; Roidl A
    Oncol Rep; 2016 Mar; 35(3):1732-40. PubMed ID: 26708059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus adenine nucleotide translocator-2 shRNA effectively induces apoptosis and enhances chemosensitivity by the down-regulation of ABCG2 in breast cancer stem-like cells.
    Jang JY; Kim MK; Jeon YK; Joung YK; Park KD; Kim CW
    Exp Mol Med; 2012 Apr; 44(4):251-9. PubMed ID: 22198296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines.
    Jandu H; Aluzaite K; Fogh L; Thrane SW; Noer JB; Proszek J; Do KN; Hansen SN; Damsgaard B; Nielsen SL; Stougaard M; Knudsen BR; Moreira J; Hamerlik P; Gajjar M; Smid M; Martens J; Foekens J; Pommier Y; Brünner N; Schrohl AS; Stenvang J
    BMC Cancer; 2016 Jan; 16():34. PubMed ID: 26801902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells.
    Robey RW; Medina-Pérez WY; Nishiyama K; Lahusen T; Miyake K; Litman T; Senderowicz AM; Ross DD; Bates SE
    Clin Cancer Res; 2001 Jan; 7(1):145-52. PubMed ID: 11205902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of ABCC1 and ABCG2 proteins by ouabain in human breast cancer cells.
    DA Silva VA; DA Silva KA; Delou JM; DA Fonseca LM; Lopes AG; Capella MA
    Anticancer Res; 2014 Mar; 34(3):1441-8. PubMed ID: 24596392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinacrine and curcumin synergistically increased the breast cancer stem cells death by inhibiting ABCG2 and modulating DNA damage repair pathway.
    Nayak D; Tripathi N; Kathuria D; Siddharth S; Nayak A; Bharatam PV; Kundu C
    Int J Biochem Cell Biol; 2020 Feb; 119():105682. PubMed ID: 31877386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary compound isoliquiritigenin targets GRP78 to chemosensitize breast cancer stem cells via β-catenin/ABCG2 signaling.
    Wang N; Wang Z; Peng C; You J; Shen J; Han S; Chen J
    Carcinogenesis; 2014 Nov; 35(11):2544-54. PubMed ID: 25194164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topotecan-induced ABCG2 expression in MCF-7 cells is associated with decreased CD24 and EpCAM expression and a loss of tumorigenicity.
    Huber S; Wege AK; Bernhardt G; Buschauer A; Brockhoff G
    Cytometry A; 2015 Aug; 87(8):707-16. PubMed ID: 25892097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2).
    Jiao X; Zhao L; Ma M; Bai X; He M; Yan Y; Wang Y; Chen Q; Zhao X; Zhou M; Cui Z; Zheng Z; Wang E; Wei M
    Breast Cancer Res Treat; 2013 Jun; 139(3):717-30. PubMed ID: 23780685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.